The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Bias in Observational Studies of Prevalent Users: Lessons for Comparative Effectiveness Research From a Meta-Analysis of Statins
Open accessAbstract
Randomized clinical trials (RCTs) are usually the preferred strategy with which to generate evidence of comparative effectiveness, but conducting an RCT is not always feasible. Though observational studies and RCTs often provide comparable estimates, the questioning of observational analyses has recently intensified because of randomized-observational discrepancies regarding the effect of postmenopausal hormone replacement therapy on coronary heart disease. Reanalyses of observational data that excluded prevalent users of hormone replacement therapy led to attenuated discrepancies, which begs the question of whether exclusion of prevalent users should be generally recommended. In the current study, the authors evaluated the effect of excluding prevalent users of statins in a meta-analysis of observational studies of persons with cardiovascular disease. The pooled, multivariate-adjusted mortality hazard ratio for statin use was 0.77 (95% confidence interval (CI): 0.65, 0.91) in 4 studies that compared incident users with nonusers, 0.70 (95% CI: 0.64, 0.78) in 13 studies that compared a combination of prevalent and incident users with nonusers, and 0.54 (95% CI: 0.45, 0.66) in 13 studies that compared prevalent users with nonusers. The corresponding hazard ratio from 18 RCTs was 0.84 (95% CI: 0.77, 0.91). It appears that the greater the proportion of prevalent statin users in observational studies, the larger the discrepancy between observational and randomized estimates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Cholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
Sever, P. S., Dahlöf, B., Poulter, N. R., Wedel, H., Beevers, G., Caulfield, M., Collins, R., Kjeldsen, S. E., Kristinsson, A., McInnes, G. T., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12948-0 · Cited by 3,782
Colhoun, H. M., Betteridge, D. J., Durrington, P. N., Hitman, G. A., W Neil, H. A., Livingstone, S. J., Thomason, M. J., Mackness, M. I., Charlton-Menys, V., & Fuller, J. H. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16895-5 · Cited by 3,755
SCANDINAVIANSIMVASTATINSURVIVAL (1994) · The Lancet · doi:10.1016/s0140-6736(94)90566-5 · Cited by 3,645
Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000344393.60303.0a · Cited by 3,641
Shepherd, J., Blauw, G. J., Murphy, M. B., Bollen, E. L., Buckley, B. M., Cobbe, S. M., Ford, I., Gaw, A., Hyland, M., Jukema, J. W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11600-x · Cited by 3,378
PEDERSEN, T. R. (2004) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2004.08.027 · Cited by 3,106
High-Dose Atorvastatin after Stroke or Transient Ischemic Attack
The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061894 · Cited by 2,887
A structural approach to selection bias
Hernán, M. A., Hernández-Díaz, S., & Robins, J. M. (2004) · Epidemiology · doi:10.1097/01.ede.0000135174.63482.43 · Cited by 2,844
Self-citationEstrogen plus Progestin and the Risk of Coronary Heart Disease
Manson, J. E., Hsia, J., Johnson, K. C., Rossouw, J. E., Assaf, A. R., Lasser, N. L., Trevisan, M., Black, H. R., Heckbert, S. R., Detrano, R., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030808 · Cited by 2,065
Statins for the primary prevention of cardiovascular disease
Taylor, F., Huffman, M. D., Macedo, A. F., Moore, T. H., Burke, M., Davey Smith, G., Ward, K., Ebrahim, S., & Gay, H. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004816.pub5 · Cited by 1,934
Prescribing Personalized Nutrition for Cardiovascular Health: Are We Ready?
Juma, S., Imrhan, V., Vijayagopal, P., & Prasad, C. (2014) · Lifestyle Genomics · doi:10.1159/000370213 · Cited by 1,891
Evaluating medication effects outside of clinical trials: new-user designs
Ray, W. A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg231 · Cited by 1,646
The Framingham Study: The Epidemiology of Atherosclerotic Disease
Dawber, T. R. (1980) · Harvard University Press eBooks · doi:10.4159/harvard.9780674492097 · Cited by 1,454
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.23.2998 · Cited by 1,331
Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease
Grodstein, F., Stampfer, M. J., Manson, J. E., Colditz, G. A., Willett, W. C., Rosner, B., Speizer, F. E., & Hennekens, C. H. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608153350701 · Cited by 1,305
Effect of Statins on Risk of Coronary Disease: A Meta-analysis of Randomized Controlled Trials
LaRosa, J. C., He, J., & Vupputuri, S. (1999) · JAMA · doi:10.1001/jama.282.24.2340 · Cited by 1,246
Nakamura, H., Arakawa, K., Itakura, H., Kitabatake, A., Goto, Y., Toyota, T., Nakaya, N., Nishimoto, S., Muranaka, M., Yamamoto, A., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69472-5 · Cited by 941
Furberg, C. D., Adams, H. P., Applegate, W. B., Byington, R. P., Espeland, M. A., Hartwell, T., Hunninghake, D. B., Lefkowitz, D. S., Probstfield, J., & Riley, W. A. (1994) · Circulation · doi:10.1161/01.cir.90.4.1679 · Cited by 867
Hernán, M. A., Alonso, A., Logan, R., Grodstein, F., Michels, K. B., Willett, W. C., Manson, J. E., & Robins, J. M. (2008) · Epidemiology · doi:10.1097/ede.0b013e3181875e61 · Cited by 818
Self-citationBrugts, J. J., Yetgin, T., Hoeks, S. E., Gotto, A. M., Shepherd, J., Westendorp, R. G. J., de Craen, A. J. M., Knopp, R. H., Nakamura, H., Ridker, P., et al. (2009) · BMJ · doi:10.1136/bmj.b2376 · Cited by 792
Serruys, P. W. J. C. (2002) · JAMA · doi:10.1001/jama.287.24.3215 · Cited by 719
Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS)
MAAS Investigators (1994) · The Lancet · doi:10.1016/s0140-6736(94)92082-6 · Cited by 647
Blankenhorn, D. H., Azen, S. P., Kramsch, D. M., Mack, W. J., Cashin-Hemphill, L., Hodis, H. N., DeBoer, L. W. V., Mahrer, P. R., Masteller, M. J., Vailas, L. I., et al. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-10-199311150-00002 · Cited by 637
Wilson, P. W. F., Garrison, R. J., & Castelli, W. P. (1985) · New England Journal of Medicine · doi:10.1056/nejm198510243131702 · Cited by 601
Knopp, R. H., d’Emden, M., Smilde, J. G., Pocock, S. J., & on behalf of the ASPEN Study Group (2006) · Diabetes Care · doi:10.2337/dc05-2415 · Cited by 550
Salonen, R., Nyyssönen, K., Porkkala, E., Rummukainen, J., Belder, R., Park, J.-S., & Salonen, J. T. (1995) · Circulation · doi:10.1161/01.cir.92.7.1758 · Cited by 540
Athyros, V. G., Papageorgiou, A. A., Mercouris, B. R., Athyrou, V. V., Symeonidis, A. N., Basayannis, E. O., Demitriadis, D. S., & Kontopoulos, A. G. (2002) · Current Medical Research and Opinion · doi:10.1185/030079902125000787 · Cited by 533
Early Statin Treatment Following Acute Myocardial Infarction and 1-Year Survival
Stenestrand, U. (2001) · JAMA · doi:10.1001/jama.285.4.430 · Cited by 530
Waters, D., Higginson, L., Gladstone, P., Kimball, B., Le May, M., Boccuzzi, S. J., & Lespérance, J. (1994) · Circulation · doi:10.1161/01.cir.89.3.959 · Cited by 499
Ray, K. K. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.182 · Cited by 446
Primary Prevention of Cardiovascular Mortality and Events With Statin Treatments
Mills, E. J., Rachlis, B., Wu, P., Devereaux, P. J., Arora, P., & Perri, D. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.039 · Cited by 423
Air Force/Texas Coronary Atherosclerosis Prevention Study
佐々木, 淳. (2008) · Japanese journal of clinical medicine · Cited by 411
Mills, E. J., WU, P., Chong, G., Ghement, I., Singh, S., Akl, E. A., Eyawo, O., Guyatt, G., Berwanger, O., & Briel, M. (2011) · QJM · doi:10.1093/qjmed/hcq165 · Cited by 338
Mora, S., Glynn, R. J., Hsia, J., MacFadyen, J. G., Genest, J., & Ridker, P. M. (2010) · Circulation · doi:10.1161/circulationaha.109.906479 · Cited by 327
MacLehose, Reeves, Harvey, Sheldon, Russell, & Black (2000) · Health Technology Assessment · doi:10.3310/hta4340 · Cited by 311
Statins for the primary prevention of cardiovascular disease
Taylor, F., Ward, K., Moore, T. H., Burke, M., Davey Smith, G., Casas, J. P., & Ebrahim, S. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004816.pub4 · Cited by 305
Cheung, B. M. Y., Lauder, I. J., Lau, C., & Kumana, C. R. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2003.02060.x · Cited by 304
Danaei, G., Rodríguez, L. A. G., Cantero, O. F., Logan, R., & Hernán, M. A. (2013) · Statistical Methods in Medical Research · doi:10.1177/0962280211403603 · Cited by 292
Self-citationKoren, M. J., & Hunninghake, D. B. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.07.053 · Cited by 280
Effectiveness of Statin Therapy in Adults With Coronary Heart Disease
Wilt, T. J., Bloomfield, H. E., MacDonald, R., Nelson, D., Rutks, I., Ho, M., Larsen, G., McCall, A., Pineros, S., & Sales, A. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.13.1427 · Cited by 275
Teo, K. K., Burton, J. R., Buller, C. E., Plante, S., Catellier, D., Tymchak, W., Dzavik, V., Taylor, D., Yokoyama, S., & Montague, T. J. (2000) · Circulation · doi:10.1161/01.cir.102.15.1748 · Cited by 275
Serruys, P. (1999) · European Heart Journal · doi:10.1053/euhj.1998.1150 · Cited by 259
Schneeweiss, S., Patrick, A. R., Stürmer, T., Brookhart, M. A., Avorn, J., Maclure, M., Rothman, K. J., & Glynn, R. J. (2007) · Medical Care · doi:10.1097/mlr.0b013e318070c08e · Cited by 253
PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA
SHEPHERD, J., COBBE, S. M., FORD, I., ISLES, C. G., LORIMER, A. R., MACFARLANE, P. W., MCKILLOP, J. H., & PACKARD, C. J. (2004) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2004.08.029 · Cited by 245
Herrington, D. M., Vittinghoff, E., Lin, F., Fong, J., Harris, F., Hunninghake, D., Bittner, V., Schrott, H. G., Blumenthal, R. S., & Levy, R. (2002) · Circulation · doi:10.1161/01.cir.0000019406.74017.b2 · Cited by 235
Kertai, M. D., Boersma, E., Westerhout, C. M., Domburg, R. V., Klein, J., Bax, J. J., Urk, H. V., & Poldermans, D. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.08.029 · Cited by 233
An application of propensity score matching using claims data
Seeger, J. D., Williams, P. L., & Walker, A. M. (2005) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1062 · Cited by 218
Clinical Outcomes in Statin Treatment Trials: A Meta-analysis
Ross, S. D., Allen, I. E., Connelly, J. E., Korenblat, B. M., Smith, M. E., Bishop, D., & Luo, D. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.15.1793 · Cited by 217
Prioritizing Comparative-Effectiveness Research — IOM Recommendations
Iglehart, J. K. (2009) · New England Journal of Medicine · doi:10.1056/nejmp0904133 · Cited by 215
Abraham, N. S., Byrne, C. J., Young, J. M., & Solomon, M. J. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.04.005 · Cited by 209
Hormone Replacement Therapy and Incidence of Acute Myocardial Infarction
Varas‐Lorenzo, C., García‐Rodríguez, L. A., Perez‐Gutthann, S., & Oliart, A. D. (2000) · Circulation · doi:10.1161/01.cir.101.22.2572 · Cited by 150
Schanzer, A. S., Hevelone, N. D., Owens, C. D., Beckman, J. A., Belkin, M., & Conte, M. S. (2008) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2007.11.056 · Cited by 150
Amarenco, P., Bogousslavsky, J., Callahan, A. S., III, Gold, L. B., Hennerici, M. G., Rudolph, A. E., Sillesen, H. H., Simunovic, L., Szarek, M. J., Welch, K. M. A., et al. (2006) · Cited by 145
Hippisley‐Cox, J., & Coupland, C. A. C. (2005) · BMJ · doi:10.1136/bmj.330.7499.1059 · Cited by 142
Petretta, M., Costanzo, P., Perrone-Filardi, P., & Chiariello, M. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.08.001 · Cited by 141
Impact of Statin Use on Outcomes After Coronary Artery Bypass Graft Surgery
Kulik, A., Brookhart, M. A., Levin, R., Ruel, M., Solomon, D. H., & Choudhry, N. K. (2008) · Circulation · doi:10.1161/circulationaha.108.799445 · Cited by 136
Horne, B. D., Muhlestein, J. B., Carlquist, J. F., Bair, T. L., Madsen, T. E., Hart, N. I., & Anderson, J. L. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00950-5 · Cited by 131
Koren, M. J., & Hunninghake, D. B. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2004.12.117 · Cited by 129
Maycock, C. A. A., Muhlestein, J. B., Horne, B. D., Carlquist, J. F., Bair, T. L., Pearson, R. R., Li, Q., & Anderson, J. L. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02477-4 · Cited by 127
The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study
Mikhailidis, D. P., & Wierzbicki, A. S. (2002) · Current Medical Research and Opinion · doi:10.1185/030079902125000778 · Cited by 124
Anderssen, S. A., Hjelstuen, A., Hjermann, I., Bjerkan, K. K., & Holme, I. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.08.033 · Cited by 122
Riegger, G. A. J., Abletshauser, C., Ludwig, M. Z., SCHWANDT, P., Widimsky, J., Jr., Weidinger, G., & Welzel, D. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00062-3 · Cited by 117
Statin therapy improves cardiovascular outcome of patients with peripheral artery disease
Schillinger, M. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.02.012 · Cited by 117
Statistical Issues Arising in the Women's Health Initiative
Prentice, R. L., Pettinger, M. B., & Anderson, G. L. (2005) · Biometrics · doi:10.1111/j.0006-341x.2005.454_1.x · Cited by 109
Flaker, G. C., Warnica, J. W., Sacks, F. M., Moyé, L. A., Davis, B. R., Rouleau, J. L., Webel, R. R., Pfeffer, M. A., & Braunwald, E. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00145-x · Cited by 104
Lemaître, R. N., Psaty, B. M., Heckbert, S. R., Kronmal, R. A., Newman, A. B., & Burke, G. L. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.12.1395 · Cited by 99
Ward, R. P., Leeper, N. J., Kirkpatrick, J. N., Lang, R. M., Sorrentino, M. J., & Williams, K. A., Sr. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.10.030 · Cited by 84
Simes, R. J. (2002) · European Heart Journal · doi:10.1053/euhj.2001.2775 · Cited by 84
Foody, J. M., Rathore, S. S., Galusha, D. H., Masoudi, F. A., Havranek, E. P., Radford, M. J., & Krumholz, H. M. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.00635.x · Cited by 83
The neglected purpose of comparative-effectiveness research
Naik, A. D., & Petersen, L. A. (2009) · New England Journal of Medicine · doi:10.1056/nejmp0902195 · Cited by 67
Leeper, N. J., Ardehali, R., deGoma, E. M., & Heidenreich, P. A. (2007) · Circulation · doi:10.1161/circulationaha.107.694117 · Cited by 66
Health Care Reform and the Need for Comparative-Effectiveness Research
Mushlin, A. I., & Ghomrawi, H. (2010) · New England Journal of Medicine · doi:10.1056/nejmp0912651 · Cited by 63
Does Comparative Effectiveness Have a Comparative Edge?
Alexander, G. C., & Stafford, R. S. (2009) · JAMA · doi:10.1001/jama.2009.851 · Cited by 60
de Liefde, I. I., Hoeks, S. E., van Gestel, Y. R. B. M., Bax, J. J., Klein, J., van Domburg, R. T., & Poldermans, D. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.05.032 · Cited by 54
Preadmission statin use and one-year mortality among patients in intensive care - A cohort study
Christensen, S., Thomsen, R. W., Johansen, M. B., Pedersen, L. H., Jensen, R. H., Larsen, K. M., Larsson, A., Tønnesen, E., & Sørensen, H. T. (2010) · Critical Care · doi:10.1186/cc8902 · Cited by 49
Reduction in coronary events during treatment with pravastatin
Furberg, C. D., Pitt, B., Byington, R. P., Park, J.-S., McGovern, M. E., & The PLAC I and PLAC II Investigators (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80472-x · Cited by 46
Weiner, M. G., Xie, D., & Tannen, R. L. (2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1585 · Cited by 46
Feringa, H. H. H., Bax, J. J., Karagiannis, S. E., Noordzij, P. G., van Domburg, R., Klein, J., & Poldermans, D. (2008) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2007.11.003 · Cited by 42
Colivicchi, F., Guido, V., Marco Tubaro, U., Ammirati, F., MONTEFOSCHI, N., Varveri, A., & Santini, M. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02711-x · Cited by 40
Furlan, A. D., TOMLINSON, G. A., Jadad, A. R., & Bombardier, C. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.04.019 · Cited by 38
The American Heart Association’s Principles for Comparative Effectiveness Research
Gibbons, R. J., Gardner, T. J., Anderson, J. L., Goldstein, L. B., Meltzer, N. M., Weintraub, W. S., & Yancy, C. W. (2009) · Circulation · doi:10.1161/circulationaha.109.192518 · Cited by 38
Sato, H., Kinjo, K., Ito, H., Hirayama, A., Nanto, S., Fukunami, M., Nishino, M., Lim, Y.-J., Kijima, Y., Koretsune, Y., et al. (2007) · Circulation Journal · doi:10.1253/circj.72.17 · Cited by 36
Discussion on "Statistical Issues Arising in the Women's Health Initiative"
Hernán, M. Á., Robins, J. M., & Rodríguez, L. A. G. (2005) · Biometrics · doi:10.1111/j.0006-341x.2005.454_7.x · Cited by 35
Self-citationSex differences in the effectiveness of statins after myocardial infarction
Karp, I., Chen, S.-F., & Pilote, L. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.060627 · Cited by 34
Gardette, V., Bongard, V., Dallongeville, J., Arveiler, D., Bingham, A., Ruidavets, J., Amouyel, P., Haas, B., Ducimetière, P., & Ferrières, J. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.09.092 · Cited by 33
Carrier, M., Cossette, M., Pellerin, M., Hébert, Y., Bouchard, D., Cartier, R., Demers, P., Jeanmart, H., Pagé, P., & Perrault, L. P. (2009) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2009.04.097 · Cited by 33
Yokoi, H., Nobuyoshi, M., Mitsudo, K., Kawaguchi, A., Yamamoto, A., & for the ATHEROMA Study Group (2005) · Circulation Journal · doi:10.1253/circj.69.875 · Cited by 30
Nagashima, M., Koyanagi, R., Kasanuki, H., Hagiwara, N., Yamaguchi, J., Atsuchi, N., Honda, T., Haze, K., Sumiyoshi, T., Urashima, M., et al. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.01.024 · Cited by 30
Welten, G. M. J. M., Chonchol, M., Hoeks, S. E., Schouten, O., Dunkelgrün, M., van Gestel, Y. R. B. M., Goei, D., Bax, J. J., van Domburg, R. T., & Poldermans, D. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.06.040 · Cited by 30
Early effects of statins in patients with coronary artery disease and high C-reactive protein
Muhlestein, J. B., Anderson, J. L., Horne, B. D., Carlquist, J. F., Bair, T. L., Bunch, T. J., & Pearson, R. R. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.07.074 · Cited by 29
Ošťádal, P., Alan, D., Vejvoda, J., Kukačka, J., Maçek, M., Hájek, P., Mates, M., Kvapil, M., Kettner, J., Wiendl, M., et al. (2010) · Trials · doi:10.1186/1745-6215-11-61 · Cited by 29
Furukawa, Y., Taniguchi, R., Ehara, N., Ozasa, N., Haruna, Y., Saito, N., Doi, T., Hoshino, K., Shizuta, S., Morimoto, T., et al. (2008) · Circulation Journal · doi:10.1253/circj.cj-08-0293 · Cited by 25
Nakagawa, T., Kobayashi, T., Awata, N., Sato, S., Reiber, J. H. C., Nakajima, H., Toyama, Y., Hiraoka, H., Kato, O., Kirino, M., et al. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.11.002 · Cited by 24
Authors' Response, Part I: Observational Studies Analyzed Like Randomized Experiments
Hernán, M. Á., & Robins, J. M. (2008) · Epidemiology · doi:10.1097/ede.0b013e318188e85f · Cited by 24
Self-citationReduced Mortality Rates after Intensive Statin Therapy in Managed-Care Patients
Fintel, D. J., Joyce, A. T., Mackell, J. A., Graff, J. S., Kuntze, E., & Ollendorf, D. A. (2007) · Value in Health · doi:10.1111/j.1524-4733.2006.00163.x · Cited by 22
Beneficial effects of statins after percutaneous coronary intervention
Zhang, Z.-J., Marroquin, O. C., Weissfeld, J. L., Stone, R. A., Mulukutla, S. R., Williams, D. O., Selzer, F., & Kip, K. E. (2009) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e32832a4e3b · Cited by 19
Sheng, X., Wei, L., Murphy, M. J., & MacDonald, T. M. (2009) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-009-0720-x · Cited by 18
Cooke, C., Kirkland, S., SKETRIS, I. S., & Cox, J. L. (2009) · BMC Health Services Research · doi:10.1186/1472-6963-9-198 · Cited by 15
Luca, G. D., Suryapranata, H., Ottervanger, J. P., Hof, A. W. J. V. ’., Hoorntje, J. C. A., Gosselink, A. T. M., Dambrink, J. E., & de Boer, M. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.11.028 · Cited by 14
Short-Term Statin Exposure Is Associated With Reduced All-Cause Mortality in Persons With Diabetes
Zhang, Q., Safford, M. M., Miller, D. R., Crystal, S., Rajan, M., Tseng, C., & POGACH, L. M. (2007) · Medical Care · doi:10.1097/01.mlr.0000250227.94196.f0 · Cited by 10
Chikamori, T., Sugimoto, K., Hamada, T., Kitaoka, H., Furuno, T., Seo, H., & Doi, Y. (2000) · PubMed · Cited by 6
NHS Evidence: better and faster access to information
Leng, G. C. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60786-8 · Cited by 5
Explaining heterogeneity in meta-analysis: a comparison of methods
Thompson, S. G., & Sharp, S. J. (1999) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19991030)18:20
Cited by
Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease
Lazarus, B., Chen, Y., Wilson, F. P., Sang, Y., Chang, A. R., Coresh, J., & Grams, M. E. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.7193 · Cited by 729
Causal inference and longitudinal data: a case study of religion and mental health
VanderWeele, T. J., Jackson, J. W., & Li, S. (2016) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-016-1281-9 · Cited by 322
Outcome-Wide Longitudinal Designs for Causal Inference: A New Template for Empirical Studies
VanderWeele, T. J., Mathur, M. B., & Chen, Y. (2020) · Statistical Science · doi:10.1214/19-sts728 · Cited by 310
Danaei, G., Rodríguez, L. A. G., Cantero, O. F., Logan, R., & Hernán, M. A. (2013) · Statistical Methods in Medical Research · doi:10.1177/0962280211403603 · Cited by 292
Self-citationMaciejewski, M. L. (2020) · Biostatistics & Epidemiology · doi:10.1080/24709360.2018.1477468 · Cited by 259
Metadata
- Authors
- Danaei, G., Tavakkoli, M., & Hernán, M. A.
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-01-05
- Volume
- 175
- Issue
- 4
- Pages
- 250-262
- ISSN
- 0002-9262 (ISSN-L)
- 1476-6256
- OpenAlex
- W2125241858
- Cited by
- 264
- References
- 115
- FWCI
- 3.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.